Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor alpha variable 8-6 (TRAV8-6) is a gene segment that encodes a variable region of the human T cell receptor alpha (TCRα) chain. The TCR is a heterodimeric cell surface complex (usually αβ chains) on T lymphocytes, responsible for recognizing antigens presented by major histocompatibility complex (MHC) molecules. The TRAV8-6 segment undergoes somatic recombination with joining (J) gene segments to generate the variable domain of the TCRα chain, contributing to the diversity of T cell responses. This gene segment is not a functional protein or therapeutic target by itself, but is one of many Vα gene segments used in constructing functional TCRs. Diversity in Vα usage underlies the specificity and breadth of the adaptive immune repertoire. Key context: TRAV8-6 is a DNA segment, not a standalone protein or receptor. T cell receptor diversity is generated by recombination of V (variable), J (joining), and C (constant) gene segments. The antigen receptor formed by T cells (TCR αβ or γδ) mediates T cell recognition of antigen–MHC complexes, triggering immune responses. Only after recombination, expression, and association with additional TCR subunits does a TCR Vα (such as from TRAV8-6) participate in T cell activation. For most biomedical applications outside immunogenetics research, TRAV8-6 would not be considered a therapeutic target or marker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor alpha variable 8-6 (TRAV8-6).